A clinical questing examination to verify vasculo-protective effect of azilsartan treatment in uncontrolled hypertensive patients with diabetes mellitus.
Phase of Trial: Phase II
Latest Information Update: 04 Apr 2017
Price : $35 *
At a glance
- Drugs Azilsartan (Primary)
- Indications Hypertension
- Focus Pharmacodynamics
- 31 Mar 2017 Status changed from recruiting to discontinued.
- 01 Apr 2014 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network Japan.
- 02 Oct 2013 New trial record